Molecular mechanisms of tumor metastasis and angiogenesis

Langenbeck's Archives of Surgery

Volumn 384, Issue 2, 1999, Pages 133-140

  Bohle A S ^a   Kalthoff, H ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Angiogenesis; Anoikis; Immunologic escape; Tumor metastases; Tumor host interaction

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; CYTOKINE; FUMAGILLOL CHLOROACETYLCARBAMATE; GROWTH FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE INHIBITOR; PENTOSAN POLYSULFATE; THALIDOMIDE; VASCULOTROPIN;

ANGIOGENESIS; CELL ADHESION; DIGESTIVE SYSTEM CANCER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TUMOR CELL;

APOPTOSIS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MOLECULAR BIOLOGY; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TUMOR ESCAPE;

EID: 0038431219     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050183     Document Type: Review

References (63)

1. Fidler IJ (1990) Critical factors in the biology of human cancer metastasis. Twenty-eighth G. H. A. Clowes Memorial Award lecture. Cancer Res 50:6130-6138
2. Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139-146
3. Takeichi M (1991) Cadherin cell adhesion receptors as morphogenetic regulators. Science 251:1451-1455
4. Gofuku J, Shiozaki H, Tsujinaka T, Inoue M, Tamura S, Doki Y, Matsui S, Tsukita S, Kikkawa N, Monden M (1999) Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma: correlation with cancer invasion and metastasis. Am J Clin Pathol 111:29-37
5. Imao T, Koshida K, Endo Y, Uchibayashi T, Namiki M (1999) Dominant role of E-cadherin in the progression of bladder cancer. J Urol 161:692-698
6. Karayannakis AJ, Syrigos KN, Chatzigianni E, Papanikolaou S, Alexiou D, Kalahanis N, Rosenberg T, Bastounis E (1998) Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res 18:4177-4180
7. Dai D, Chen J, Xu L (1997) Quantitative analysis of E-cadherin expression and clinicopathologic evaluation in gastric cancer. Chung Hua I Hsueh Tsa Chih 77:668-671
8. Berx G, Nollet F, van Roy F (1998) Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 6:171-184
9. Ogawa Y, Hirakawa K, Nakata B, Fujihara T, Sawada T, Kato Y, Yoshikawa K, Sowa M (1998) Expression of intercellular adhesion molecule 1 in invasive breast cancer reflects low growth potential, negative lymph node involvement and good prognosis. Clin Cancer Res 4:31-36
10. Miyake S, Nagai K, Yoshino K, Otto M, Endo M, Yuasa Y (1994) Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 54:3007-3010
11. Frisch SM, Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9:701-706
12. Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H (1997) Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 57:3106-3110
13. Vogel I, Krüger U, Marxsen J, Soeth E, Kalthoff H, Henne-Bruns D, Kremer B, Juhl H (1999) Isolated tumor cells in pancreatic cancer patients detected by immunocytology: a new prognostic factor. Clin Cancer Res (in press)
14. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
15. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reunig U, Ulm K, Hofler H, Janicke F, Graeff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis. Thromb Haemost 78:285-296
16. Ignar DM, Andrews JL, Witherspoon SM, Leray JD, Clay WC, Kilpatrick K, Onori J, Kost T, Emerson DL (1998) Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist. Clin Exp Metastasis 16:9-20
17. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160
18. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65
19. Sato H, Seiki M (1996) Membrane-type melalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 119:209-215
20. Takanami I, Takeuchi K, Naruke M, Kodaira S, Tanaka F, Watanabe H, Raz A (1998) Autocrine motility factors in pulmonary adenocarcinomas: results of an immunohistochemical study. Tumor Biol 19:384-389
21. Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H, Raz A (1996) Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br J Cancer 74:2003-2007
22. Stracke ML, Claire T, Liotta LA (1997) Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 37:135-144
23. Hu M, Pollock RE, Nakamura T, Nicholson GL (1995) Human peri-tumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains. Int J Cancer 62:585-592
24. Hynes RO (1987) Integrins: a family of cell surface receptors. Cell 48:549-554
25. Ghadimi BM, Schlag PM (1998) Tumormetastasierung. Molekulare Grundlagen und therapeutische Optionen. Chirurg 69:1315-1322
26. Buckley CD, Pilling D, Henriquez NV, Parsonage G, Threlfall K, Scheel-Toellner D, Simmons DL, Akbar AN, Lord JM, Salmon M (1999) RGD peptides induce apoptosis by direct caspase-3 activation. Nature 397:534-539
27. Shinohara M, Nakamura S, Sasaki M, Kurahara S, Ikebe T, Harada T, Shirasuna K (1999) Expression of integrins in squamous cell carcinoma of the oral cavity. Correlation with tumor invasion and metastasis. Am J Clin Pathol 111:75-88
28. Ura H, Denno R, Hirata K, Yamaguchi K, Yoshima T (1998) Separate functions of alpha2beta 1 and alpha 3beta 1 integrins in the metastatic process of gastric cancer. Surg Today 28:1001-1006
29. Pasqualini R, Bourdoulos S, Koivunen E, Woods VL Jr, Ruoslahti E (1996) A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat Med 2:1197-1203
30. O'Connel J, O'Sullivan GC, Collins JK, Shanahan F (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075-1082
31. Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H (1998) Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 58:1741-1749
32. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon-j: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245-254
33. Passlick B, Pantel K, Kubuschok B, Angstwurm M, Neher A, Thetter O, Schweiberer L, Izbicki JR (1996) Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumor cells. Eur J Cancer 32:141-145
34. Webb DSA, Mostowsky HS, Gerrard TL (1991) Cytokine induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J Immunol 146:3682-3686
35. Seliger B, Hohne A, Knuth A, Bernhard H, Meyer T, Tampe R, Momburg F, Huber C (1996) Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res 56:1756-1760
36. Samak R, Edelstein R, Israel L (1982) Immunosuppressive effect of acute-phase reactant proteins in vitro and its relevance to cancer. Cancer Immunol Immunother 13:38-43
37. Narayanan S (1994) Sialic acid as a tumor marker. Ann Clin Lab Sci 24:376-384
38. Amado M, Carneiro F, Seixas M, Clausen H, Sobrino-Simoes M (1998) Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114:462-470
39. Nakamori S, Furukawa H, Hiratsuka M, Iwanaga T, Imaoka S, Ishikawa O, Kabuto T, Sasaki Y, Kameyama M, Ishiguro S, Irimura T (1997) Expression of carbohydrate antigen sialyl Le (a): a new functional prognostic factor in gastric cancer. J Clin Oncol 15:816-825
40. Saiki I, Murata J, Iida J, Sakurai T, Nishi N, Matsuno K, Azuma I (1989) Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences. Br J Cancer 60:722-728
41. Brodt P, Fallavolita L, Bresalier RS, Meterissian S, Norton CR, Wolitzki BA (1997) Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71:612-619
42. Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, Altevogt P, Ley K (1998) CD 24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 12:1241-1251
43. Honn KV, Tang DG (1997) Eicosanoid 12(S)-HETE upregulates endothelial cell alpha V beta 3 integrin expression and promotes tumor cell adhesion to the vascular endothelium. Adv Exp Med Biol 4008:765-773
44. Degen WG, van Kempen LC, Gijzen EG, van Groningen JJ, van Kooyk Y, Bloemers HP, Swart GW (1998) MEMD, a new cell adhesion molecule in human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am J Pathol 152:805-813
45. Lewalle JM, Bajou K, Desreux J, Mareel M, Dejana E, Noel A, Foidart JM (1997) Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res 237:347-356
46. Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes Memorial Award Lecture. Cancer Res 46:467-473
47. Ellis LM, Fidler IJ (1996) Angiogenesis and metastasis. Eur J Cancer 32:2451-2460
48. O'Reilly MS, Holmgren L, Chen C, Folkman J (1996) Angiostalin induces and sustains dormancy of human primary tumors in mice. Nat Med 2:689-692
49. Liotta LA, Kleinerman J, Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation Cancer Res 34:997-1003
50. Folkman J (1995) Clinical applications of research on angiogenesis. New Engl J Med 333:1757-1763
51. Ishigami SI, Arii S, Furutani M, Niwane M, Harada T, Mizumoto M, Mori A, Onodera H, Imamura M (1998) Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer 78:1379-1384
52. Kieser A, Weich HA, Brandner G, Marme D, Kolch W (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor. Oncogene 9:963-969
53. Siemeister G, Martiny-Baron G, Marme D (1998) The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Rev 17:241-248
54. Marme D (1999) Tumorangiogenese: Molekulare Fakten und therapeutische Möglichkeiten. Chirurg 70:31-35
55. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA (1994) Integrin alpha Vbeta3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1167
56. Moenner M, Gusse M, Hatzi E, Badet J (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur J Biochem 226:483-490
57. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG (1996) Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res 56:2703-2706
58. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR, Ellis LM (1996) Platelet derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 88:1146-1151
59. Ellis LM, Liu W, Wilson BS (1996) Down regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery 120:871-878
60. Kim KJ, Li B, Winer J, Armannini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844
61. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579
62. Zhu Z, Rockwell P, Lu D, Kotanides H, Pytowsky B, Hicklin DJ, Bohlen P, Witte L (1998) Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library. Cancer Res 58:3209-3214
63. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285